Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03348384 · ClinicalTrials.gov registry record · Early Phase 1
[11C]NOP-1A and Cocaine Use Disorders
A Early Phase 1 study of Cocaine Use Disorder, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 49
- Enrollment target
- 1
- Study location
NCT03348384 is a Early Phase 1 study of Cocaine Use Disorder that has completed, run by University of Pittsburgh. The registered enrollment target is 49 participants, below the 102-participant average among 26 other Cocaine Use Disorder trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03348384, a Early Phase 1 study of Cocaine Use Disorder, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 49 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to compared \[C-11\]NOP-1A binding in recently abstinent cocaine use disorders and controls.
Conditions Studied
Interventions
- RADIATION [C-11]
- DRUG NOP-1A
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2014-10-30 |
| Est. Completion | 2019-02-20 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03348384
The ClinicalTrials.gov registry entry for NCT03348384 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 102-participant average among 26 other Cocaine Use Disorder trials with a reported enrollment target (52% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cocaine Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which [C-11] is the first listed.
NCT03348384 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03348384 about?
NCT03348384 is a clinical study titled "[11C]NOP-1A and Cocaine Use Disorders". The goal of this study is to compared \[C-11\]NOP-1A binding in recently abstinent cocaine use disorders and controls.
What is the current status of trial NCT03348384?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 49 participants. The study started on 2014-10-30. Estimated completion is 2019-02-20.
What conditions does trial NCT03348384 study?
This clinical trial studies the following conditions: Cocaine Use Disorder.
What interventions are being tested in trial NCT03348384?
The interventions under investigation include: [C-11] (RADIATION), NOP-1A (DRUG).
Who is sponsoring clinical trial NCT03348384?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03348384 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cocaine and Pentoxifylline (BED IN 47)
RECRUITING · Early Phase 1
-
Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)
RECRUITING · Early Phase 1
-
Imaging CRF X NOP Interactions in CUD
RECRUITING · Early Phase 1
-
[C-11]NPA PET-amphetamine in Cocaine Use Disorders
RECRUITING · Early Phase 1
-
Safety Profile of Psilocybin for Cocaine Use Disorder
RECRUITING · Early Phase 1
-
Targeting Drug Memories With Methylphenidate
ACTIVE NOT RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.